How to improve the outcomes of elderly acute myeloid leukemia patients through allogeneic hematopoietic stem cell transplantation

In recent years, with the gradual advancement of haploidentical transplantation technology, the availability of donors has increased significantly, along with the widespread use of reduced-intensity conditioning and the improvement of nursing techniques, giving more elderly acute myeloid leukemia (AML) patients the chance to receive allogeneic hematopoietic stem cell transplantation. We have summarized the classic and recently proposed pre-transplant assessment methods and assessed the various sources of donors, conditioning regimens, and post-transplant complication management based on the outcomes of large-scale clinical studies for elderly AML patients.

Automated summary

In recent years, haploidentical transplantation technology has advanced, leading to increased availability of donors and improved conditions for elderly AML patients to receive allogeneic hematopoietic stem cell transplantation. This article summarizes the pre-transplant assessment methods, various sources of donors, conditioning regimens, and post-transplant complication management based on large-scale clinical studies.